AMiAware is the Winner at Boston Scientific Connected Patient Challenge

Posted · Add Comment

AMiAware, by unanimous decision, took First Place at the Boston Scientific Challenge. VantageLinks CEO, Leah Amir, heads the AMiAware development team. The patented technology is guiding the path to timely meaningful clinical decisions. The prognostic markers have over 12 years of study to verify their role in plaque rupture. Through collaboration with the Mayo Clinic and Boston Scientific the FDA clearance process is underway. Enjoy our segment of Boston Scientific Challenge presentation, edited for time.

For More Information

contact us